QuidelOrtho Corp. Aktie
39,40 €
Deine Einschätzung
QuidelOrtho Corp. Aktie
Was spricht für und gegen QuidelOrtho Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von QuidelOrtho Corp. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
QuidelOrtho Corp. | -1,48 % | 0,00 % | 15,20 % | -47,63 % | -41,91 % | -61,54 % | -24,78 % |
Illumina Inc. | 0,81 % | -0,71 % | 10,27 % | -22,19 % | -8,61 % | -71,16 % | -53,23 % |
Waters Corp. | -0,26 % | -1,48 % | 10,31 % | 22,40 % | 1,32 % | -11,05 % | 61,44 % |
Boston Scientific | -1,39 % | 0,00 % | -2,07 % | 53,18 % | 38,02 % | 89,59 % | 92,02 % |
Kommentare
News
QuidelOrtho to Participate in Upcoming Investor Conferences
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine
QuidelOrtho Reports Second Quarter 2024 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs, and
QuidelOrtho to Report Second Quarter 2024 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and